Pharmaceutical

Patients are no longer willing to buy a drug just because a doctor is recommending it. There is an increasing shift in patients expecting drug developers and drug companies to help them achieve their health goals rather than simply providing a product. This demand is creating opportunities for the pharma companies to work on enhanced patient engagement solutions.

With significant efforts and large investments, pharma companies are taking next-gen breakthroughs of treatments to patients faster through digital health solutions. Meanwhile, healthcare organizations are moving towards the holistic treatment of a disease in such a way that it will result in the best therapeutic benefits for patients. This growing interdependence of pharma and healthcare has increased the need for brand positions of therapeutic drugs to be supported by clinical and real-world evidence. With patients and decision-makers having more access to information than ever before, pharma companies are looking to conform to experience, behavior and changing needs to thrive in the competitive market. There is an expectation that big data and AI will demonstrate their value to the pharma world.

The pharmaceutical industry is at a crucial turning point. On the one hand, tech-savvy and well-informed patients are demanding personalized experiences and self-health management, and on the other hand, organizations are looking for a better pharmaceutical digital strategy and ways to measure or intervene to improve human health, optimizing patient care and health outcomes. This changing landscape is driving life sciences companies to go beyond the pill by engaging directly with patients to improve their products as well as patient outcomes. This requires significant investments in platforms that support real-world data, patient workflow and commercial operations.

Patients today rely on digital health apps to improve their mental health, track fitness, and optimize overall wellbeing. Besides introducing innovative applications to extend self-management, leveraging connected health through wearables to get real-time data and generate actionable insights on the unique behavioral pattern for each patient is helping pharma companies deliver a proactive and personalized patient experience. Furthermore, with evidence-based software-driven therapeutic interventions, pharmaceutical organizations can improve medication adherence and engagement of chronically ill patients.